health
Hosted by Tumori Journal · health · EN-US
TJ Talks is an educational initiative featuring conversations about oncology led by Prof. Giancarlo Pruneri, Editor in Chief of Tumori Journal.The podcast series aims to explore a variety of topics of interest that reflect the dynamic and evolving nature of oncology research, with contributions from renowned international experts and promising young researchers in the field. Through these insightful discussions, TJ Talks seeks to support the professional development of clinicians and researchers working to improve the cancer care.Follow us on X, Bluesky and LinkedIn to always be updated on cancer research and clinical practice in oncology!
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
30%
Guest openness
Selective
Sign up to generate a grounded pitch for TJ Talks.
Signup to Generate a PitchTJ Talks is an educational initiative featuring conversations about oncology led by Prof. Giancarlo Pruneri, Editor in Chief of Tumori Journal. The podcast series aims to explore a variety of topics of interest that reflect the dynamic and evolving nature of oncology research, with contributions from renowned international experts and promising young researchers in the field.
TJ Talks is hosted by Tumori Journal. The show has published 23 episodes to date.
Recent episodes include "Palliative care in oncology: changing perceptions, improving care" (16 October 2026, 23 minutes), "Interdisciplinary Innovations in Epigenetics and CAR-T Cell Therapy" (10 September 2026, 13 minutes), and "Early Diagnosis as a Determinant of Childhood Cancer Survival: Insights from the BENCHISTA Project" (9 July 2026, 21 minutes).
TJ Talks publishes roughly monthly, with episodes averaging 17 minutes across 23 episodes.
Booking probability for TJ Talks is 30%, and the host is rated Selective on guests. TJ Talks requires a Pod Score of 80 or higher. TJ Talks's contact route on record: verified email.
The strongest fits for TJ Talks are Doctors & Physicians. TJ Talks has a health audience.
Tumori Journal hosts TJ Talks, a health podcast with 23 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
TJ Talks
Why is palliative care still so often seen as a last resort and what would it take to change that? In this episode of TJ Talks , Professors Claudia Gamondi (Head of the Palliative and Supportive Care service at...
TJ Talks
Real breakthroughs happen when the research brings together different skills, knowledge and passion. Discover an inspiring perspective on interdisciplinary approaches to CAR-T cell therapies in this episode...
Episode #18
The BENCHISTA – International Benchmarking of Childhood Cancer Survival by Tumor stage – project is a worldwide collaboration led by University College London (UCL) and Fondazione IRCCS...
Episode #17
<p>What emerges from the most recent first line trials is that the progress in advanced ovarian cancer depends not only on new treatment, but on the better patient selection: not all patients are in the same situation...
Episode #16
<p>Caught between enthusiasm for technical innovation and the need for a critical assessment of research practices, the oncology is seeking a new path that offers real hope for effective treatments and a fair...
Episode #15
<p>Imparare a governare l'innovazione: questo l'invito che il cosiddetto Common Sense Oncology rivolge alla comunità oncologica per un approccio terapeutico interamente centrato sui bisogni del paziente. Alla base del...
Episode #14
<p>From advances in the screening of prostate cancer to the management of the genitourinary tumors, the GU oncology addresses ever more clinical challenges. </p> <p>What are the most relevant challenges in the...
Episode #13
<p>The choice of an endpoint can really change the way a treatment is administered or approved for use on patients. And in the future, we will see much more data on quality of life, and trials will probably also work on...
Episode #12
<p>Pharmaco-prevention of breast cancer is an evidence-based strategy that uses drugs to reduce the risk of disease in high-risk women. However, the use of this strategy remains modest due to concerns about toxicity...
Episode #11
<p>Stories of foreign cancer patients who ask to return to their country at the end of their lives: their deep desire to see their loved ones one last time is intertwined with medical, legal and financial issues that...
Episode #11
<p>Storie di pazienti oncologici stranieri che chiedono di tornare nel loro Paese per il fine vita: attorno al desiderio profondo di rivedere ancora una volta i propri cari si intrecciano questioni mediche, legali...
Episode #10
<p>Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in the oncology drug approval pathway by European Medicines Agency (EMA) is very...
Episode #9
<p >Le parole del prof. Paolo Marchetti restituiscono il quadro complesso dell’oncologia di precisione con il ritmo epico delle grandi imprese di frontiera. E’ lui - Professore Ordinario di Oncologia Medica...
Episode #9
<p>In this episode of TJ Talks, the guest is Professor Paolo Marchetti, a well-known expert in precision oncology in Italy, Full Professor of Medical Oncology at the University of Rome "La Sapienza", Scientific Director...
Episode #8
<p>If we were to stop at a first glance, the use of liquid biopsy would be limited in the clinical practice of colorectal cancer to cases where tumour tissue is unavailable or insufficient. In reality, we are at the...
Episode #7
<p>The field of bioinformatics is rapidly evolving, shaping the future of biomedical research and precision medicine. From cutting-edge advancements in computational biology to AI-driven solutions, what will the...
Episode #6
<p>Drug resistance is a major challenge in oncology and genetically-engineered mouse models represent powerful tools to identify new approaches for its overcoming.</p> <p>In this TJ Talks podcast, Prof Paola Perego...
Episode #5
<p>Dr. Arsela Prelaj is confident: the implementation of Artificial Intelligence in Oncology, in the near future, will be aimed at advances in screening and the use of images, such as radiomics; in digital pathology...
Episode #4
<p>In this TJ Talks podcast, Dr Luca Agnelli, Tumori Journal Section Editor for Bioinformatics, meets Prof George Calin, a distinguished scientist with an extraordinary career dedicated to studying microRNAs, non-coding...
Episode #3
<p>A scientific society for integrating all aspects of cancer care - diagnostics, pathology, surgery, radiation, and medical oncology -through a multidisciplinary approach, because the future of medical oncology will...
Recent guests on TJ Talks. Study who booked and why before you pitch.
Emeritus Professor of Paediatric Oncology, University College London Great Ormond Street Institute of Child Health
Pharmacology Section Editor, Adjunct Professor at the University of Insubria, Tumori Journal
Director of the Early Drug Development for Innovative Therapies Division, European Institute of Oncology and University of Milan
Memorial Sloan Kettering
PitchCentric classifies TJ Talks under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
OncTimes Talk
JCO Precision Oncology Conversations
OncTimes Talk
DrTalk | Oncology
JAMA Oncology Author Interviews
Journal of Clinical Oncology (JCO) Podcast
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ